Panel: Quality Improvement in Addiction Medicine (2017)
This presentation is part of the Addiction Medicine Review Course 2017, an overview of the core elements of addiction medicine, presented by top experts in the field. Together with the other presentation it can serve as a broad review for clinicians, a review of the basics for newcomers, or a starting point for those preparing to sit for the Board of Addiction Exam.
- Addiction medicine specialists who want an overview of the latest developments in the field and their relevance to clinical practice
- Primary care clinicians who want to get a better understanding of addiction and manage patients with addictions in their practice
- Public health officials who want an understanding of the current state of addiction treatment
- Non-physicians who are involved in the treatment of addiction
After participating in this training the learner should:
- Explain how principles of quality improvement relate to addiction medicine
- Overcome objections to building QI into an addiction medicine program
Lei Choi, MD
Dr. Lei Choi joined UCSF Health in 2015. She is the Medical Director of the Lean Transformation Office and a practicing physician in the UCSF Division of General Internal Medicine. In 2015, Dr. Choi joined the faculty at UCSF Health as the Medical Director of the Lean Transformation Office. She is dedicated to coaching Lean leader behaviors, empowering innovative problem solvers throughout the organization, and advancing the delivery of highly reliable patient-centered care.
Priscillia Hunt, PhD
Dr. Hunt is a Full Economist at RAND, Professor at Pardee RAND Graduate School, and Research Fellow with the Institute for the Study of Labor. Priscillia has been studying drug markets and illicit and licit drug policy at RAND for eight years , and has recently been working on a series of studies calculating the resources used to prepare and implement continuous quality improvement programs in substance abuse treatment facilities and primary care clinics. Her other published works include a book chapter on the licit and illicit supply-chain for presription drugs in the US, a study on the effects of recreational marijuana legalization on affordability of marijuana in Colorado and Washington, a study “Sizing National Heroin Markets in the EU”, and a series of chapters in understanding illicit drug markets, supply-reduction efforts, and drug-related crime in the EU. Dr. Hunt has published studies on drug policy, methods in using drug survey data, cost-benefit of drug treatment, and criminal behavior in journals such as Drug Policy Analysis, Addiction Science & Clinical Practice Journal of Criminal Psychology, and Journal of Experimental Criminology.
Ingeborg Schafhalter-Zoppoth, MD
Dr. Ingeborg Schafhalter-Zoppoth is an internist and primary care physician at CPMC/SPMF board-certified in internal medicine and addiction medicine. After completion of her medical training in Austria she worked as researcher at UCSF and finished her residency in internal medicine/ primary care at Alameda County Medical Center. She now works as clinician educator for the CPMC internal medicine residency program where she teaches outpatient management, addiction medicine and quality improvement. Dr. Schafhalter-Zoppoth is an associate professor at the University of California San Francisco.
Katherine E. Watkins, MD
Dr. Watkins is a Senior Natural Scientist at the RAND Corporation. She combines a research background in substance abuse and mental health treatment services, with a clinical background in treatment for substance use and co-occurring disorders. Her research focuses on measuring the quality of behavioral health care, developing and evaluating interventions for individuals with co-occurring mental and substance-use disorders, and integrating addiction treatment into primary care settings. The long-term goal of Dr. Watkins’ research is to improve access and the quality of care provided to individuals with mental illness and substance use disorders, using both quantitative and qualitative research methods.
Drs. Choi, Hunt, Watkins and Schafhalter-Zoppoth have no relevant financial relationships
The California Society of Addiction Medicine (CSAM) is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this edduring internet-based educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This credit may also be applied to the CMA Certification in Continuing Medical Education.
- 1.00 AMA Category 1
- 1.00 Attendance